Apheresis Procedure Reduces Microplastics, PFAS, and Cholesterol Levels
International endocrinologists have identified that apheresis, a medical procedure primarily designed to extract excess cholesterol from the blood, also appears to lower concentrations of perfluorinated compounds (PFAS) and microplastic particles. This study, led by Stefan Bornstein from the Dresden University of Technology, proposes that these environmental pollutants utilize lipoproteins for transport within the body. The research highlights that PFAS, often referred to as "forever chemicals," and microplastics can bind with plasma proteins and fats, effectively packaging themselves within lipoproteins. As a result, the apheresis filter captures these contaminants along with the targeted cholesterol molecules during the filtration process.
Apheresis functions as a blood filtration method aimed at treating severe lipid metabolism disorders. The procedure involves separating specific components from the blood, primarily lipoproteins that carry fats and cholesterol, removing them, and then returning the remaining blood to the patient. The researchers initially measured low-density lipoproteins and C-reactive protein—biomarkers that the apheresis method is known to eliminate. Following this, they analyzed PFAS concentrations using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The detection of PFAS in the separated fluid confirmed that these substances were successfully removed from the bloodstream. However, the data regarding microplastics yielded mixed results; in some cases, levels of certain polymer types increased in specific patients.
To explore the biological implications of these findings, the research team conducted laboratory experiments on adrenal cells. In the control group, exposure to polystyrene particles resulted in a higher cell death rate. Conversely, when polystyrene was mixed with blood serum obtained after apheresis, the damage to cells was notably reduced. This suggests that the apheresis procedure may alter the chemical composition of the plasma in a way that mitigates the toxicity of these contaminants.
Despite these promising insights, the authors caution against overinterpreting the results due to several critical limitations. Although the research sheds light on the movement of synthetic substances through the human body, large-scale clinical trials with control groups are essential before apheresis can be officially recognized as a detoxification method. The study's findings were published in the journal Genomic Press, emphasizing the need for further investigation into the efficacy and safety of this procedure for broader applications.
Important: This article is for general information and does not replace medical advice. Individuals should not start, stop, or change treatment without consulting a qualified clinician.




